睡眠呼吸暂停与卒中:叙述性综述
本综述聚焦卒中后阻塞性睡眠呼吸暂停(OSA)的诊治现状。卒中后OSA常见且与心源性栓塞性卒中及脑小血管病等亚型相关,未治疗与卒中复发、死亡及功能恢复差相关。CPAP可改善认知与神经功能恢复,但对血管事件及死亡风险的随机对照试验结果多为阴性。
要点
- 卒中后OSA常见且常被漏诊,不典型表现是原因之一。
- 未治疗的卒中后OSA与卒中复发、死亡及功能恢复差相关。
- CPAP改善认知与神经恢复,但未证实降低卒中复发与死亡。
核心结论
- 卒中后OSA需高质量随机对照试验验证CPAP等治疗对减少血管事件和死亡的作用。
- 可通过探索未试验的治疗策略、按内型和表型个体化干预、选择高危人群及采用反映OSA心血管损害生理指标的指标来实现。
研究设计与样本
- 叙述性综述,总结卒中后OSA的流行病学、诊断与治疗证据。
主要发现
- 卒中后OSA常见,与心源性栓塞性卒中和脑小血管病等多种卒中亚型密切相关。
- 观察性研究显示未治疗的卒中后OSA与卒中复发、死亡、功能恢复差和住院时间延长相关。
- 随机对照试验显示CPAP治疗改善认知和神经功能恢复等非血管结局。
- 评估CPAP对卒中复发风险和死亡影响的随机对照试验结果多为阴性。
关键数值与推荐
- 推荐使用便携式睡眠监测或实验室多导睡眠图等客观检测诊断OSA。
- CPAP是治疗OSA的金标准。
临床怎么用
- 对卒中患者应警惕OSA并采用客观睡眠检测进行诊断。
- 卒中后OSA可考虑CPAP治疗以改善认知和神经功能恢复。
局限性
- 缺乏高质量随机对照试验证据支持CPAP降低卒中后血管事件和死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC IMPORTANCE: Stroke is the second-leading cause of death worldwide. OSA is an independent risk factor for stroke and is associated with multiple vascular risk factors. Poststroke OSA is prevalent and closely linked with various stroke subtypes, including cardioembolic stroke and cerebral small vessel disease. Observational studies have shown that untreated poststroke OSA is associated with an increased risk of recurrent stroke, mortality, poorer functional recovery, and longer hospitalizations. REVIEW FINDINGS: Poststroke OSA tends to be underdiagnosed and undertreated, possibly because patients with stroke and OSA present atypically compared with the general population with OSA. Objective testing, such as the use of ambulatory sleep testing or in-laboratory polysomnography, is recommended for diagnosing OSA. The gold standard for treating OSA is CPAP therapy. Randomized controlled trials have shown that treatment of poststroke OSA using CPAP improves nonvascular outcomes such as cognition and neurologic recovery. However, findings from randomized controlled trials that have evaluated the effect of CPAP on recurrent stroke risk and mortality have been largely negative. SUMMARY: There is a need for high-quality randomized controlled trials in poststroke OSA that may provide evidence to support the utility of CPAP (and/or other treatment modalities) in reducing recurrent vascular events and mortality. This goal may be achieved by examining treatment strategies that have yet to be trialed in poststroke OSA, tailoring interventions according to poststroke OSA endotypes and phenotypes, selecting high-risk populations, and using metrics that reflect the physiologic abnormalities that underlie the harmful effects of OSA on cardiovascular outcomes.
引用
- Dharmakulaseelan L, Boulos MI. Sleep Apnea and Stroke: A Narrative Review. Chest. 2024. PMID: 38815623. doi:10.1016/j.chest.2024.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。